Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Wednesday, February 5, 2025.
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)
Strong Downtrend (-100) - ORMP is in a strong downtrend that is likely to continue. With short-term, intermediate, and long-term bearish momentum, ORMP continues to fall. Traders should use caution and set stops.
Is it time to buy, sell, or avoid ORMP?
MarketClub looks at technical strength and momentum to determine if the timing is right for ORMP.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for ORMP
The long-term trend has been DOWN since Jun 5th, 2024 at 2.14
The intermediate-term trend has been DOWN since Jan 13th, 2025 at 2.32
The short-term trend has been DOWN since Jan 17th, 2025 at 2.32
Smart Scan Analysis for ORMP
Based on our trend formula, ORMP is rated as a -100 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 2.18 | 2.20 | 2.16 | 2.18 | +0.02 |
| Prev. Close | Volume | Bid | Ask | Time |
| 2.19 | 44163 | 2025-02-04 15:45:25 |
| Year High | 9.24 | Year High Date | 2018-01-05 |
| Year Low | 3.91 | Year Low Date | 2018-11-13 |
| 52wk High | 3.67 | 52wk High Date | 2024-02-27 |
| 52wk Low | 2 | 52wk Low Date | 2024-06-10 |
| Year End Close | 3.96 | Average Volume | 114,774 |
| Shares Outstanding | 40,312 | % Institutional | 10.1 |
| Market Cap | 50M | Assets | 165,081,000M |
| Liabilities | 8,640,000M | P/E Ratio | 19.6364 |
| Beta | -0.15000000 | Volatility | 42.29 |